2011-15 FASEB Summer Conference on Autoimmunity
2011-15 FASEB Summer Conference on Autoimmunity
批准号:
8128001
负责人:
Joan M Goverman
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2016-04-30
关键词:
Applied ResearchAreaAtherosclerosisAutoimmune DiseasesAutoimmune ProcessAutoimmune ResponsesAutoimmunityB cell differentiationB-LymphocytesBasic ScienceBiological Response Modifier TherapyCellsChronic DiseaseClinicalClinical TrialsCollaborationsCommunicationComplexDataDevelopmentDiseaseDrug DesignDrug IndustryEconomicsEnsureEnvironmentEtiologyExposure toFailureFertilizationFutureGenderGeneticGenetic Predisposition to DiseaseGoalsGrowthHealthHealth Care CostsHumanImmuneImmune systemIncidenceIndustryInflammation MediatorsInsulin-Dependent Diabetes MellitusInvestigationKnowledgeLaboratoriesLocationMediatingMediator of activation proteinMolecularNatureObesityParticipantPathogenesisPathway interactionsPharmaceutical PreparationsPharmacologic SubstancePostdoctoral FellowQuality of lifeRegulatory T-LymphocyteResearchResearch PersonnelRoleScientistSocietiesStressStudentsT-LymphocyteTNF geneTherapeuticTherapeutic InterventionTimeTranslatingTranslationsTreatment EfficacyUnderrepresented MinorityWorkbaseclinically significantcytokinedata exchangeeffective therapyinsightinterestknowledge translationmeetingsmicrobiomenovelnovel strategiesnovel therapeutic interventionnovel therapeuticsplanetary Atmosphereposterspreventprogramsrituximabsuccesssymposiumtherapeutic targettraffickingtrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There has been enormous growth in the past few years in our understanding of pathogenic mechanisms in autoimmunity, and a new recognition of the similarities and important differences between different autoimmune diseases. Examples of rapidly moving areas of research in autoimmunity are the identification and characterization of new subsets of pathogenic T cells that secrete unique inflammatory mediators and novel insights into the interface between genetic susceptibility, environmental stress and the microbiome. These findings have emerged largely from the work of basic scientists, and this FASEB summer conference on Autoimmunity has historically focused on discussion of new findings in basic research in autoimmunity. However, we believe that it is crucial for basic scientists to establish and maintain connections to scientists who are working to translate mechanisms into therapeutic targets. For example, the unexpected efficacy of therapeutic B cell depletion in some autoimmune diseases has prompted intense investigation by basic scientists into the role of B cells in pathogenic pathways. Therefore, while maintaining a focus on cutting edge basic research in autoimmunity, new sessions will be included in these conferences in which translational scientists are invited to discuss new strategies for treating autoimmune diseases with biologics, and current data on the successes and failures of manipulating the immune system in humans with autoimmune disease. We expect that increased emphasis on therapeutic treatment of autoimmune disease will attract both basic and industry scientists, and will stimulate strong interest among both junior and established investigators. The size and setting of this meeting are ideal to promote the open exchange of data and cross-fertilization of ideas that will stimulate new hypotheses and directions in autoimmunity research.
PUBLIC HEALTH RELEVANCE: Autoimmune diseases are debilitating, chronic diseases resulting in significant decrease in quality of life. The incidence of autoimmunity has risen over the past decade such that collectively these disease exert a significant economic toll on society due to loss of livelihood and cost of health care. The goal of the FASEB Summer Conferences on Autoimmunity is to provide a forum for the exchange of data, ideas and hypotheses between basic and applied scientists in order to catalyze the development of new treatments for autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms by which CD8 T cells shape CNS autoimmunity initiated by CD4 T cells
-
批准号:8561026
-
项目类别:
-
资助金额:$45.27万
-
财政年份:2013
-
负责人:Joan M Goverman
-
依托单位:
Mechanisms by which CD8 T cells shape CNS autoimmunity initiated by CD4 T cells
-
批准号:8676651
-
项目类别:
-
资助金额:$48.19万
-
财政年份:2013
-
负责人:Joan M Goverman
-
依托单位:
Mechanisms by which CD8 T cells shape CNS autoimmunity initiated by CD4 T cells
-
批准号:9926209
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2013
-
负责人:Joan M Goverman
-
依托单位:
Mechanisms by which CD8 T cells shape CNS autoimmunity initiated by CD4 T cells
-
批准号:9276483
-
项目类别:
-
资助金额:$48.19万
-
财政年份:2013
-
负责人:Joan M Goverman
-
依托单位:
MOG-Specific T Cell Trafficking in the Central Nervous System
-
批准号:7371787
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2008
-
负责人:Joan M Goverman
-
依托单位:
MOG-Specific T Cell Trafficking in the Central Nervous System
-
批准号:7759163
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2008
-
负责人:Joan M Goverman
-
依托单位:
MOG-Specific T Cell Trafficking in the Central Nervous System
-
批准号:8210953
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2008
-
负责人:Joan M Goverman
-
依托单位:
MOG-Specific T Cell Trafficking in the Central Nervous System
-
批准号:8013051
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2008
-
负责人:Joan M Goverman
-
依托单位:
MOG-Specific T Cell Trafficking in the Central Nervous System
-
批准号:7560053
-
项目类别:
-
资助金额:$43.73万
-
财政年份:2008
-
负责人:Joan M Goverman
-
依托单位:
MECHANISMS OF TOLERANCE AND IMMUNITY TO CENTRAL NERVOUS SYSTEM ANTIGENS
-
批准号:7568240
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2007
-
负责人:Joan M Goverman
-
依托单位:
MECHANISMS OF TOLERANCE AND IMMUNITY TO CENTRAL NERVOUS SYSTEM ANTIGENS
-
批准号:7759161
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2007
-
负责人:Joan M Goverman
-
依托单位:
MECHANISMS OF TOLERANCE AND IMMUNITY TO CENTRAL NERVOUS SYSTEM ANTIGENS
-
批准号:7197192
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2007
-
负责人:Joan M Goverman
-
依托单位:
MECHANISMS OF TOLERANCE AND IMMUNITY TO CENTRAL NERVOUS SYSTEM ANTIGENS
-
批准号:7356052
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2007
-
负责人:Joan M Goverman
-
依托单位:
MECHANISMS OF TOLERANCE AND IMMUNITY TO CENTRAL NERVOUS SYSTEM ANTIGENS
-
批准号:8013872
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2007
-
负责人:Joan M Goverman
-
依托单位:
Regulatory T cells in MBP-Specific Autoimmunity
-
批准号:6623532
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2002
-
负责人:Joan M Goverman
-
依托单位:
Regulatory T cells in MBP-Specific Autoimmunity
-
批准号:6712812
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2002
-
负责人:Joan M Goverman
-
依托单位:
Regulatory T cells in MBP-Specific Autoimmunity
-
批准号:7037560
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2002
-
负责人:Joan M Goverman
-
依托单位:
Regulatory T cells in MBP-Specific Autoimmunity
-
批准号:6466697
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2002
-
负责人:Joan M Goverman
-
依托单位:
Regulatory T cells in MBP-Specific Autoimmunity
-
批准号:6884635
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2002
-
负责人:Joan M Goverman
-
依托单位:
Events Leading to Loss Of Tolerance to Myelin Basic Pro*
-
批准号:6644130
-
项目类别:
-
资助金额:$22.74万
-
财政年份:2001
-
负责人:Joan M Goverman
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: